Contract award · W81XWH19C0108
ARMY R&D MEDICAL CONTRACT SBIR PHASE II, PROPOSAL NO. A2-7599, TITLED, " 3IN1 AN INNOVATIVE PRODUCT TO STABILIZE AND CONCENTRATE BIOMOLECULAR SPECIES FROM HUMAN SERUM AND URINE SAMPLES", TOPIC NUMBER A17-131
Awarded to LYNNTECH INC. · CAGE 0LHF9
Latest reported total obligated
Not reported
Net observed obligations
$1M
Observed contract actions
5
Observed period
FY2019–FY2023
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorLYNNTECH INC.
CAGE0LHF9
CustomerDepartment of the Army
Performance locationCOLLEGE STATION, TEXAS, UNITED STATES
Procurement details
First observed actionSep 20, 2019
Latest observed actionMar 21, 2023
PSCAN91
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
SolicitationHQ003418RODAB
Annual observed obligations
FY2019
$634K
FY2020
$366K
Continue exploring
Ask Mimir about W81XWH19C0108
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.